Matinas BioPharma Holdings (MTNB) Revenue (2015 - 2023)
Matinas BioPharma Holdings (MTNB) posted quarterly Revenue of $721000.0 for Q2 2023, down 32.17% year-over-year from $1.1 million in Q2 2022, and up 92.27% quarter-over-quarter from $375000.0 in Q1 2023.
Matinas BioPharma Holdings (MTNB) Revenue (2015 - 2023) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Revenue for 8 consecutive years, with $721000.0 the latest figure, recorded in Q2 2023.
- In Q2 2023, Revenue fell 32.17% year-over-year to $721000.0; the TTM figure through Dec 2023 stood at $1.1 million (down 65.63% YoY), while the FY2023 annual figure was $1.1 million, down 65.62% from the prior year.
- Revenue advanced to $721000.0 in Q2 2023 per MTNB's latest filing, from $375000.0 in the prior quarter.
- Across five years, Revenue topped out at $1.1 million in Q2 2022 and bottomed at -$62833.0 in Q4 2020.
- Historically, Revenue has averaged $444081.2 across 5 years, with a median of $235416.5 in 2020.
- Annual changes were most pronounced in 2022 — Revenue jumped 319319.22% — and 2023, when it sank 32.17%.
- Matinas BioPharma Holdings' Revenue stood at $89812.0 in 2019, then sank by 169.96% to -$62833.0 in 2020, then surged by 99.47% to -$333.0 in 2021, then surged by 319319.22% to $1.1 million in 2022, then tumbled by 32.17% to $721000.0 in 2023.
- Business Quant data shows MTNB's Revenue at $721000.0 in Q2 2023, $375000.0 in Q1 2023, and $1.1 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Matinas BioPharma Holdings | 1.19 Mn | 375,426.61 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 721,000.00 |
| Mar 31, 2023 | 375,000.00 |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 1.06 Mn |
| Dec 31, 2021 | -333.00 |
| Mar 31, 2021 | 33,333.00 |
| Dec 31, 2020 | -62,833.00 |
| Sep 30, 2020 | 95,833.00 |
| Jun 30, 2019 | 89,812.00 |
| Jun 30, 2018 | 89,813.00 |
| Mar 31, 2018 | 29,937.00 |
| Dec 31, 2017 | 44,906.00 |
| Sep 30, 2017 | 44,906.00 |
| Jun 30, 2017 | 44,906.00 |
| Mar 31, 2017 | 14,969.00 |
| Sep 30, 2015 | 59,858.00 |
| Jun 30, 2015 | 77,000.00 |
| Mar 31, 2015 | 57,636.00 |